A Win For Adaptive Biotechnologies Corporation
Fri, May 02, 2025 at 07:37 PM
Adaptive Biotechnologies Corporation (ADPT:NASDAQ) soared at $9.84, a gain of 33.7%. On Fri, May 02, 2025, ADPT:NASDAQ hit a New 2-Week High of $9.84. The stock appeared on our News Catalysts scanner on Fri, May 02, 2025 at 02:51 PM in the 'BIOTECH' category. From Mon, Apr 21, 2025, the stock recorded 55.56% Up Days and 40.00% Green Days
About Adaptive Biotechnologies Corporation (ADPT:NASDAQ)
Adaptive Biotechnologies Corp is a a commercial-stage company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease in patients with select blood cancers.
Top 10 Gainers:
- Polyrizon Ltd. (PLRZ:NASDAQ), 298.58%
- Freight Technologies Inc Com (FRGT:NASDAQ), 111.21%
- IBO (Listing Market - NYSE Amex (IBO:NYSEMKT), 87%
- Click Holdings Limited (CLIK:NASDAQ), 59.43%
- Cooper-Standard Holdings Inc. (CPS:NYSE), 43.76%
- Santech Holdings Ltd ADS (STEC:NASDAQ), 38.41%
- FST Corp. (KBSX:NASDAQ), 35.33%
- Classover Holdings Inc. (KIDZ:NASDAQ), 33.96%
- Inozyme Pharma Inc. (INZY:NASDAQ), 33.88%
- Adaptive Biotechnologies Corporation (ADPT:NASDAQ), 33.7%